Conversant Bio Awards Aurora Health Care $50,000 Grant

Share Article

Award to Help Further Enhance the Biorepository and Specimen Resource Center

Because patients are waiting . . .

For more information, visit www.conversantbio.com/join-our-study.

We know that researchers should have quick access to samples, and we recognize that valuable samples are being lost due to the issue of financial sustainability." Marshall Schreeder, CEO of Conversant Bio

Conversant Bio today announced that it has awarded Milwaukee-based Aurora Health Care a $50,000 grant to help further enhance its Biorepository and Specimen Resource Center (BSRC), located at Aurora St. Luke’s Medical Center.

The award will be used to enhance all aspects of the BSRC, whose mission it is to support the scientific community in the conduct of ethical, patient-centered research to ultimately improve clinical outcomes by using BSRC-collected samples to study a range of conditions, including Alzheimer’s disease, ovarian cancer and congestive heart failure.

As a part of the grant, an advisory board of experts in the technical and regulatory aspects of biobanking, including key representatives from the International Society for Biological and Environmental Repositories and National Institutes of Health, will assess all aspects of the BSRC and then provide recommendations to help augment the center’s work.

“With the help of this grant, we aim to build upon the great work of our biorepository team and further maximize the research we’re conducting, which will, ultimately, help provide for better patient outcomes,” said Kurt Waldhuetter, vice president of Aurora Research Institute.

“Extending this grant to Aurora Health Care is a natural extension of our mission,” said Marshall Schreeder, chief executive officer of Conversant Bio. “We know that researchers should have quick access to samples, which is critical in changing health care and bringing about better patient care.”

Conversant Bio’s mission is to improve human health by connecting patients, medical professionals and the research community to catalyze breakthrough research and novel therapeutic solutions. The company is driven to promote new and innovative solutions to these problems. They want to be a partner in research and development with the hope that the challenges associated with obtaining high quality biospecimens will become a thing of the past.

About Conversant Bio
Conversant Bio works with researchers around the world to provide them with tissue samples in order to conduct informed, cutting edge investigations into many of today's most problematic diseases. With a large collection network of 50+ U.S.-based clinical sites, and an IRB reviewed chain of custody Quality Control System, Conversant Bio provides the highest quality samples on time, and on budget. For additional information about Conversant Bio’s services, please visit the company’s website.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Larson Hicks

Rebecca Parker
@ConversantBIO
Follow >
Conversant Bio
since: 10/2014
Like >
Conversant Biologics, Inc.

Follow us on
Visit website